Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for NGM BIOPHARMACEUTICALS INC
Goto 0, 1, 2, ...5, 6, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-06-09
Purchase
2022-06-13
5:05 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
984,161 $13.5 $13,286,174 18,143,374
(Indirect
Direct)
View
2022-06-09
Purchase
2022-06-13
4:58 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
984,161 $13.5 $13,286,174 18,143,374
(Indirect
Direct)
View
2022-06-09
Purchase
2022-06-13
4:56 pm
NGM BIOPHARMACEUTICALS INC NGM GOEDDEL DAVID V
Director
10% Owner
984,161 $13.5 $13,286,174 18,274,374
(Indirect
Direct)
View
2022-06-02
Purchase
2022-06-06
4:44 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
34,200 $13.03 $445,739 18,110,897
(Indirect
Direct)
View
2022-06-02
Purchase
2022-06-06
4:43 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
34,200 $13.03 $445,739 18,110,897
(Indirect
Direct)
View
2022-06-02
Purchase
2022-06-06
4:40 pm
NGM BIOPHARMACEUTICALS INC NGM GOEDDEL DAVID V
Director
10% Owner
34,200 $13.03 $445,739 18,241,897
(Indirect
Direct)
View
2022-05-31
Purchase
2022-06-02
4:28 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
153,806 $13.46 $2,069,667 18,109,768
(Indirect
Direct)
View
2022-05-31
Purchase
2022-06-02
4:26 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
153,806 $13.46 $2,069,667 18,109,768
(Indirect
Direct)
View
2022-05-31
Purchase
2022-06-02
4:22 pm
NGM BIOPHARMACEUTICALS INC NGM GOEDDEL DAVID V
Director
10% Owner
153,806 $13.46 $2,069,667 18,240,768
(Indirect
Direct)
View
2022-05-26
Purchase
2022-05-31
5:02 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
22,911 $13.49 $309,035 18,104,692
(Indirect
Direct)
View
2022-05-26
Purchase
2022-05-31
4:59 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
22,911 $13.49 $309,035 18,104,692
(Indirect
Direct)
View
2022-05-26
Purchase
2022-05-31
4:58 pm
NGM BIOPHARMACEUTICALS INC NGM GOEDDEL DAVID V
Director
10% Owner
22,911 $13.49 $309,035 18,235,692
(Indirect
Direct)
View
2022-05-24
Purchase
2022-05-26
4:13 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
61,120 $13.42 $819,948 18,103,936
(Indirect
Direct)
View
2022-05-24
Purchase
2022-05-26
4:11 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
61,120 $13.42 $819,948 18,103,936
(Indirect
Direct)
View
2022-05-24
Purchase
2022-05-26
4:07 pm
NGM BIOPHARMACEUTICALS INC NGM GOEDDEL DAVID V
Director
10% Owner
61,120 $13.42 $819,948 18,234,936
(Indirect
Direct)
View
2022-05-19
Purchase
2022-05-23
4:14 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
39,700 $13.36 $530,454 18,101,919
(Indirect
Direct)
View
2022-05-19
Purchase
2022-05-23
4:12 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
39,700 $13.36 $530,454 18,101,919
(Indirect
Direct)
View
2022-05-19
Purchase
2022-05-23
4:10 pm
NGM BIOPHARMACEUTICALS INC NGM GOEDDEL DAVID V
Director
10% Owner
39,700 $13.36 $530,454 18,232,919
(Indirect
Direct)
View
2022-05-17
Purchase
2022-05-19
4:39 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
151,699 $13.33 $2,022,004 18,100,609
(Indirect
Direct)
View
2022-05-17
Purchase
2022-05-19
4:35 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
151,699 $13.33 $2,022,004 18,100,609
(Indirect
Direct)
View
2022-05-17
Purchase
2022-05-19
4:33 pm
NGM BIOPHARMACEUTICALS INC NGM GOEDDEL DAVID V
Director
10% Owner
151,699 $13.33 $2,022,004 18,231,609
(Indirect
Direct)
View
2022-05-13
Purchase
2022-05-17
4:22 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
162,531 $2.6327 $427,891 18,095,603
(Indirect
Direct)
View
2022-05-13
Purchase
2022-05-17
4:21 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
162,531 $2.6327 $427,891 18,095,603
(Indirect
Direct)
View
2022-05-13
Purchase
2022-05-17
4:18 pm
NGM BIOPHARMACEUTICALS INC NGM GOEDDEL DAVID V
Director
10% Owner
162,531 $2.6327 $427,891 18,226,603
(Indirect
Direct)
View
2022-05-11
Purchase
2022-05-13
5:32 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
166,350 $11.43 $1,902,032 18,090,240
(Indirect
Direct)
View
2022-05-11
Purchase
2022-05-13
5:30 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
166,350 $11.43 $1,902,032 18,090,240
(Indirect
Direct)
View
2022-05-11
Purchase
2022-05-13
5:27 pm
NGM BIOPHARMACEUTICALS INC NGM GOEDDEL DAVID V
Director
10% Owner
166,350 $11.43 $1,902,032 18,221,240
(Indirect
Direct)
View
2022-05-09
Purchase
2022-05-11
6:14 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
114,440 $10.95 $1,252,982 18,084,750
(Indirect
Direct)
View
2022-05-09
Purchase
2022-05-11
6:03 pm
NGM BIOPHARMACEUTICALS INC NGM COLUMN GROUP L P
Svennilson Peter
Kutzkey Tim
Ponoi Capital II LP
Ponoi II Management LLC
PONOI CAPITAL LP
Ponoi Management LLC
COLUMN GROUP II LP
Column Group Management LP
Column Group II GP LP
Director
10% Owner
114,440 $10.95 $1,252,982 18,084,750
(Indirect
Direct)
View
2022-05-09
Purchase
2022-05-11
6:01 pm
NGM BIOPHARMACEUTICALS INC NGM GOEDDEL DAVID V
Director
10% Owner
114,440 $10.95 $1,252,982 18,215,750
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-05-18
Option Award
2022-05-20
6:24 pm
N/A
2032-05-17
NGM BIOPHARMACEUTICALS INC NGM PERLMUTTER ROGER M
Director
24,222 $0 24,222
(Direct)
View
2022-05-18
Option Award
2022-05-20
6:23 pm
N/A
2032-05-17
NGM BIOPHARMACEUTICALS INC NGM Hooper Suzanne Sawochka
Director
24,222 $0 24,222
(Direct)
View
2022-05-18
Option Award
2022-05-20
6:22 pm
N/A
2032-05-17
NGM BIOPHARMACEUTICALS INC NGM Ho Carole
Director
24,222 $0 24,222
(Direct)
View
2022-05-18
Option Award
2022-05-20
6:22 pm
N/A
2032-05-17
NGM BIOPHARMACEUTICALS INC NGM GOEDDEL DAVID V
Director
10% Owner
24,222 $0 24,222
(Direct)
View
2022-05-18
Option Award
2022-05-20
6:21 pm
N/A
2032-05-17
NGM BIOPHARMACEUTICALS INC NGM Guyer Shelly D
Director
24,222 $0 24,222
(Direct)
View
2022-03-03
Option Award
2022-03-04
4:11 pm
N/A
2032-03-02
NGM BIOPHARMACEUTICALS INC NGM RIEFLIN WILLIAM JL
Chairman
80,000 $0 80,000
(Direct)
View
2022-03-03
Option Award
2022-03-04
4:11 pm
N/A
2032-03-02
NGM BIOPHARMACEUTICALS INC NGM Lieu Hsiao D
SVP Chief Medical Officer
150,000 $0 150,000
(Direct)
View
2022-03-03
Option Award
2022-03-04
4:09 pm
N/A
2032-03-02
NGM BIOPHARMACEUTICALS INC NGM CHEN JIN-LONG
Chief Scientific Officer
175,000 $0 175,000
(Direct)
View
2022-03-03
Option Award
2022-03-04
4:08 pm
N/A
2032-03-02
NGM BIOPHARMACEUTICALS INC NGM Pierce Valerie L
VP
150,000 $0 150,000
(Direct)
View
2022-03-03
Option Award
2022-03-04
4:06 pm
N/A
2032-03-02
NGM BIOPHARMACEUTICALS INC NGM WOODHOUSE DAVID J
CEO
500,000 $0 500,000
(Direct)
View
Goto 0, 1, 2, ...5, 6, Next